￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
The fourth domestic MET inhibitor: tepotinib hydrochloride was approved for marketing

2025-10-19 11:44:20

Check Details
Entrectinib purchase and analysis of its effects

2025-10-19 11:44:20

Check Details
Detailed explanation of the efficacy and side effects management of ceritinib

2025-10-19 11:44:20

Check Details
The efficacy and safety of Yiluake Tablets (Qixinke) in the treatment of lung cancer

2025-10-19 11:44:20

Check Details
Application of Yiluake Tablets (Qixinke) in the treatment of ALK-positive lung cancer

2025-10-19 11:44:20

Check Details
A brief introduction to the precautions and contraindications of the anaplastic lymphoma kinase (ALK)-positive lung cancer drug alectinib

2025-10-19 11:44:20

Check Details
The efficacy of dabrafenib in the treatment of non-small cell lung cancer

2025-10-19 11:44:20

Check Details
The mechanism and precautions of Ripotinib

2025-10-19 11:44:20

Check Details
Application of Ripotinib in the treatment of NTRK fusion-positive tumors

2025-10-19 11:44:20

Check Details
Detailed explanation of the launch time and effects of ROS1-positive lung cancer drug Ripotinib

2025-10-19 11:44:20

Check Details
Is Sotolaxib effective in treating illnesses?

2025-10-19 11:44:20

Check Details
The latest price of Sotoraxibu in 2024 published on the entire network

2025-10-19 11:44:20

Check Details
Category
相关知识